Biobank sustainability: current status and future prospects

References

• Caulfield T, Borry P, Gottweis H. Industry involvement in publicly funded biobanks. Nat Rev Genet. 2014;15(4):220.
   PubMed Web of Science ®Google Scholar
• Gee S, Georghiou L, Oliver R, Yuille M. Financing UK biobanks: rationale for a national biobanking research infrastructure. 2013. Available from: http://www.stratumbiobanking.org/docs/STRATUM%20COST%20MODEL%20FINAL%20REPORT%20MAY%202013.pdf. Accessed November 1, 2016.
   Google Scholar
• Gee S, Oliver R, Corfield J, Georghiou L, Yuille M. Biobank finances: a socio-economic analysis and review. Biopreserv Biobank. 2015;13(6):435–451.
   Web of Science ®Google Scholar
• Henderson GE, Cadigan RJ, Edwards TP, et al. Characterizing biobank organizations in the U.S.: results from a national survey. Genome Med. 2013;5(1):3.
   Google Scholar
• Hirtzlin I, Dubreuil C, Préaubert N, et al. An empirical survey on biobanking of human genetic material and data in six EU countries. Eur J Hum Genet. 2003;11(6):475–488.
   Web of Science ®Google Scholar
• Vaught J. Biobanking comes of age: the transition to biospecimen science. Annu Rev Pharmacol Toxicol. 2016;56:211–228.
   PubMed Web of Science ®Google Scholar
• Carpenter JE, Clarke CL. Biobanking sustainability: experiences of the Australian Breast Cancer Tissue Bank (ABCTB). Biopreserv Biobank. 2014;12(6):395–401.
   Web of Science ®Google Scholar
• Wilson GD, D’Angelo K, Pruetz BL, Geddes TJ, Larson DM, Akervall J. The challenge of sustaining a hospital-based biobank and core molecular laboratory: the Beaumont experience. Biopreserv Biobank. 2014;12(5):306–311.
   Web of Science ®Google Scholar
• Odeh H, Miranda L, Rao A, et al. The Biobank Economic Modeling Tool (BEMT): online financial planning to facilitate biobank sustainability. Biopreserv Biobank. 2015;13(6):421–429.
   Web of Science ®Google Scholar
• [No authors listed]. A network of bioresource facilities in Japan: the human bioresource consortium technical chapter (Japanese association for human bio-resource research). Biopreserv Biobank. 2013;11(1):57–63.
   Google Scholar
• [No authors listed]. The Spanish HIV HGM BioBank (SHIVBB). Biopreserv Biobank. 2013;11(4):253–254.
   Web of Science ®Google Scholar
• Afonso A, Pereira JP, Dias S. Biobanco-IMM, Lisbon Academic Medical Centre. Biopreserv Biobank. 2014;12(6):433–434.
   Web of Science ®Google Scholar
• Franková V, Jirsová K, Zima T. The Bank of Biological Material (BBM) of the First Faculty of Medicine of Charles University in Prague, Czech Republic. Biopreserv Biobank. 2015;13(4):299–300.
   Web of Science ®Google Scholar
• [No authors listed]. Canadian tumour repository network. Biopreserv Biobank. 2010;8(4):181–185.
   Web of Science ®Google Scholar
• [No authors listed]. The Infectious Diseases BioBank (IDB) at King’s College London, United Kingdom. Biopreserv Biobank. 2012;10(3):295–296.
   Web of Science ®Google Scholar
• Sanner JE, Nomie KJ. The biobank at the University of Texas Health Science Center at Houston. Biopreserv Biobank. 2015;13(3):224–225.
   Web of Science ®Google Scholar
• Cadigan RJ, Lassiter D, Haldeman K, Conlon I, Reavely E, Henderson GE. Neglected ethical issues in biobank management: results from a U.S. study. Life Sci Soc Policy. 2013;9(1):1.
   PubMedGoogle Scholar
• Sargsyan K, Macheiner T, Story P, et al. Sustainability in biobanking: model of Biobank Graz. Biopreserv Biobank. 2015;13(6):410–420.
   PubMed Web of Science ®Google Scholar
• Matharoo-Ball B, Thomson BJ. Nottingham Health Science Biobank: a sustainable bioresource. Biopreserv Biobank. 2014;12(5):312–316.
   Web of Science ®Google Scholar
• Clément B, Yuille M, Zaltoukal K, et al. Public biobanks: calculation and recovery of costs. Sci Transl Med. 2014;6(261):261fs45.
   Web of Science ®Google Scholar
• Parry-Jones A. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study. Biopreserv Biobank. 2014;12(6):381–388.
   PubMed Web of Science ®Google Scholar
• Seiler CY, Eschbacher J, Bowser R, LaBaer J. Sustainability in a hospital-based biobank and university-based DNA biorepository: strategic roadmaps. Biopreserv Biobank. 2015;13(6):401–409.
   PubMed Web of Science ®Google Scholar
• Albert M, Bartlett J, Johnston RN, Schacter B, Watson P. Biobank bootstrapping: Is biobank sustainability possible through cost recovery? Biopreserv Biobank. 2014;12(6):374–380.
   Web of Science ®Google Scholar
• Galbraith JW. Sustainability in the modern biorepository environment from the perspective of the Tissue Procurement Core at the University of Iowa. Biopreserv Biobank. 2015;13(6):430–432.
   Web of Science ®Google Scholar
• Imboden M, Probst-Hensch NM. Biobanking across the phenome: at the center of chronic disease research. BMC Public Health. 2013;13:1094.
   Web of Science ®Google Scholar
• de Gramont A, Watson S, Ellis LM, et al. Pragmatic issues in biomarker evaluation for targeted therapies in cancer. Nat Rev Clin Oncol. 2015;12(4):197–212.
   PubMed Web of Science ®Google Scholar
• Freedman LP, Cockburn IM, Simcoe TS. The economics of reproducibility in preclinical research. PLoS Biol. 2015;13(6):e1002165.
   PubMed Web of Science ®Google Scholar
• Nielsen J. Reach-through rights in biomedical patent licensing: a comparative analysis of their anti-competitive reach. Fed Law Rev. 2004;32(2):169–204.
   Google Scholar
• Winickoff DE. Partnership in U.K. Biobank: a third way for genomic property? J Law Med Ethics. 2007;35(3):440–456.
   PubMed Web of Science ®Google Scholar
• Pathmasiri S, Deschênes M, Joly Y, Mrejen T, Hemmings F, Knoppers BM. Intellectual property rights in publicly funded biobanks: Much ado about nothing? Nat Biotechnol. 2011;29(4):319–323.
   PubMed Web of Science ®Google Scholar
• Birch K, Dove ES, Chiappetta M, Gürsoy UK. Biobanks in oral health: promises and implications of post-neoliberal science and innovation. OMICS. 2016;20(1):36–41.
   PubMed Web of Science ®Google Scholar
• Evers K, Forsberg J, Hansson M. Commercialization of biobanks. Biopreserv Biobank. 2012;10(1):45–47.
   Web of Science ®Google Scholar
• Caulfield T, Burningham S, Joly Y, et al. A review of the key issues associated with the commercialization of biobanks. J Law Biosci. 2014;1(1):94–110.
   PubMed Web of Science ®Google Scholar
• Nicol D, Critchley C, McWhirter R, Whitton T. Understanding public reactions to commercialization of biobanks and use of biobank resources. Soc Sci Med. 2016;162:79–87.
   Web of Science ®Google Scholar
• Barnes RO, Schacter B, Kodeeswaran S, Watson PH. Funding sources for Canadian biorepositories: the role of user fees and strategies to help fill the gap. Biopreserv Biobank. 2014;12(5):300–305.
   Web of Science ®Google Scholar
• Georghiou LG, Halfpenny P. Equipping researchers for the future. Nature. 1996;383(6602):663–664.
   Web of Science ®Google Scholar
• European Union. Consolidated version of the Treaty on the Functioning of the European Union: article 107. 2012. Available from: http://eur-lex.europa.eu/legal-content/EN/TXT/?uri=celex%3A12012E%2FTXT. Accessed November 1, 2016.
   Google Scholar
• Riegman PH. From AAA+ to BB- and on the way back again. Biopreserv Biobank. 2014;12(5):292–293.
   Web of Science ®Google Scholar
• Hess DJ. Neoliberalism and the history of STS theory. Soc Epistemol. 2013;27(2):177–193.
   Web of Science ®Google Scholar
• Harris JR, Burton P, Knoppers BM, et al. Toward a roadmap in global biobanking for health. Eur J Hum Genet. 2012;20(11):1105–1111.
   PubMed Web of Science ®Google Scholar
• Biobanking and BioMolecular Resources Research Infrastructure [website on the Internet]. Available from: http://bbmri-eric.eu. Accessed September 5, 2016.
   Google Scholar
• Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance. Science. 2016;353(6302):874–875.
   PubMed Web of Science ®Google Scholar